5BLIESENER N, ALBRECHT S, SCHWAGER A, et al.Plasma testosterone and sexual function in men receivingbuprenorphine maintenance for opioid dependence[J]. JClin Endocrinol Metab, 2005, 90(1):203-206.
6NIK JAAFAR NR, MISLAN N, ABDUL AZIZ S, et al. Riskfactors of erectile dysfunction in patients receivingmethadone maintenance therapy[J]. J Sex Med, 2013, 10(8):2069-2076.
7CHOU R, WERMER MB, DANA T. Methadone overdoseand cardiac arrhythmia potential: findings from a review ofthe evidence for an American Pain Society and College onProblems of Drug Dependence clinical practice guideline[J]. J Pain, 2014, 15(4):338-365.
8KATZ DF, SUN J, KHATRI V, et al. QTc interval screeningin an opioid treatment program[J]. Am J Cardiol, 2013,112(7):1013-1018.
9ANCHERSEN K, CLAUSEN T, GOSSOP M, et al. Prevalenceand clinical relevance of corrected QT interval prolongationduring methadone and buprenorphine treatment:a mortality assessment study[J]. Addiction, 2009, 104(6):993-999.
10EHRET G.B, VOIDE C, GEX-FABRY M, et al. Drug-inducedlong QT syndrome in injection drug users receivingmethadone: high frequency in hospitalized patients and riskfactors[J]. Arch Intern Med, 2006, 166(12):1280-1287.
